卫光生物(002880.SZ)：上半年净利润1.08亿元 同比下降2.02%

Core Viewpoint - Weigao Bio (002880.SZ) reported a slight decline in revenue and net profit for the first half of 2025, indicating potential challenges in maintaining growth [1] Financial Performance - The company achieved operating revenue of 518 million yuan, a year-on-year decrease of 0.92% [1] - Net profit attributable to shareholders was 108 million yuan, down 2.02% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 106 million yuan, reflecting a year-on-year decline of 1.36% [1] - Basic earnings per share stood at 0.4746 yuan [1]